Dalotutumab, also known as Renzapride, is a benzamide derivative acting as a selective 5-HT4 receptor agonist and 5-HT3 receptor antagonist, primarily investigated for the treatment of gastrointestinal… Read more
Dalotutumab, also known as Renzapride, is a benzamide derivative acting as a selective 5-HT4 receptor agonist and 5-HT3 receptor antagonist, primarily investigated for the treatment of gastrointestinal motility disorders such as irritable bowel syndrome. Pharmaceutical laboratories utilize this category to access high-quality reference standards, including impurities, diastereomeric mixtures, and stable isotope labelled compounds, which are essential for rigorous analytical testing. These materials are critical for accurate impurity profiling, method validation, and quality control during the development and manufacturing of the active pharmaceutical ingredient. By providing consistent standards for quantitative analysis and structural identification, these products enable researchers to maintain strict compliance with regulatory benchmarks. Whether performing routine batch release testing or developing complex stability-indicating methods, professionals rely on these labelled standards and related chemical reference materials to ensure the precision and reliability of their analytical protocols.